Pacira BioSciences, Inc. (PCRX) — Cash Flow-to-Debt Ratio
Pacira BioSciences, Inc. (PCRX) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of $25.68 Million could theoretically repay 0% of its total liabilities ($554.64 Million) in one year. Explore Pacira BioSciences, Inc. (PCRX) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacira BioSciences, Inc. Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacira BioSciences, Inc. across 18 annual periods. Also explore PCRX total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pacira BioSciences, Inc. (2008–2025)
Year-by-year debt coverage analysis for Pacira BioSciences, Inc.. For market capitalisation and broader financial context, see Pacira BioSciences, Inc. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | $151.99 Million | $571.81 Million | ▲ +8.8% |
| 2024 | 0.24x | $189.39 Million | $775.17 Million | ▲ +11.3% |
| 2023 | 0.22x | $154.65 Million | $704.26 Million | ▲ +37.0% |
| 2022 | 0.16x | $145.27 Million | $906.19 Million | ▲ +71.5% |
| 2021 | 0.09x | $125.72 Million | $1.34 Billion | ▼ -20.5% |
| 2020 | 0.12x | $77.03 Million | $654.83 Million | ▼ -20.6% |
| 2019 | 0.15x | $70.52 Million | $476.12 Million | ▲ +11.6% |
| 2018 | 0.13x | $48.87 Million | $368.13 Million | ▲ +160.4% |
| 2017 | 0.05x | $17.79 Million | $348.89 Million | ▼ -73.7% |
| 2016 | 0.19x | $33.45 Million | $172.49 Million | ▲ +14.5% |
| 2015 | 0.17x | $29.00 Million | $171.23 Million | ▲ +3.0% |
| 2014 | 0.16x | $25.47 Million | $154.93 Million | ▲ +148.9% |
| 2013 | -0.34x | $-43.22 Million | $128.57 Million | ▲ +77.9% |
| 2012 | -1.52x | $-70.13 Million | $46.20 Million | ▼ -219.4% |
| 2011 | -0.48x | $-31.00 Million | $65.22 Million | ▼ -119.6% |
| 2010 | -0.22x | $-24.88 Million | $114.94 Million | ▲ +30.5% |
| 2009 | -0.31x | $-20.84 Million | $66.90 Million | ▲ +54.1% |
| 2008 | -0.68x | $-29.19 Million | $43.05 Million | — |